These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7294424)

  • 1. Dose response to intramuscular succinylcholine in children.
    Liu LM; DeCook TH; Goudsouzian NG; Ryan JF; Liu PL
    Anesthesiology; 1981 Nov; 55(5):599-602. PubMed ID: 7294424
    [No Abstract]   [Full Text] [Related]  

  • 2. Is intramuscular mivacurium an alternative to intramuscular succinylcholine?
    Cauldwell CB; Lau M; Fisher DM
    Anesthesiology; 1994 Feb; 80(2):320-5. PubMed ID: 8311314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suxamethonium--electromyographic studies in children.
    Brown TC; Meretoja OA; Bell B; Clare D
    Anaesth Intensive Care; 1990 Nov; 18(4):473-6. PubMed ID: 2268011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotonic and neuromuscular blocking effects of increased doses of suxamethonium in infants and children.
    Meakin G; Walker RW; Dearlove OR
    Br J Anaesth; 1990 Dec; 65(6):816-8. PubMed ID: 2265051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The action of Succinylcholine on the isolated rat diaphragm.
    Paradelis AG; Logaras G
    Arzneimittelforschung; 1973 Aug; 23(8):1046-8. PubMed ID: 4801025
    [No Abstract]   [Full Text] [Related]  

  • 6. Does suxamethonium influence the subsequent dose requirements of alcuronium and its reversibility in children?
    Brown TC; Meretoja OA; Clare D; Bell B
    Anaesth Intensive Care; 1990 Nov; 18(4):479-82. PubMed ID: 2268013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation between tetanic fade and receptor occlusion in the presence of competitive neuromuscular block.
    Waud BE; Waud DR
    Anesthesiology; 1971 Nov; 35(5):456-64. PubMed ID: 4329144
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuromuscular blockade in infants following intramuscular succinylcholine in two or five per cent concentration.
    Sutherland GA; Bevan JC; Bevan DR
    Can Anaesth Soc J; 1983 Jul; 30(4):342-6. PubMed ID: 6871775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of neuromuscular transmission. Significance of the mode of S.C.C. administration in the development of phase II block].
    Murakami S; Kuze S; Kobayashi T
    Masui; 1970 Oct; 19(11):1225-34. PubMed ID: 5528946
    [No Abstract]   [Full Text] [Related]  

  • 10. Characteristics of the neuromuscular block with succinylcholine and decamethonium in man.
    De Jong RH; Freund FG
    Anesthesiology; 1967; 28(3):583-91. PubMed ID: 6023529
    [No Abstract]   [Full Text] [Related]  

  • 11. The nature of suxamethonium neuromuscular block in the dog assessed by train-of-four stimulation.
    Cullen LK; Jones RS
    Res Vet Sci; 1980 Nov; 29(3):281-8. PubMed ID: 7255890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between succinylcholine and ranitidine in rats.
    Mishra Y; Ramzan I
    Can J Anaesth; 1993 Jan; 40(1):32-7. PubMed ID: 8381053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular blockade in a patient with stiff-baby syndrome.
    Cook WP; Kaplan RF
    Anesthesiology; 1986 Nov; 65(5):525-8. PubMed ID: 3777485
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid neuromuscular blockade: are there alternatives to succinylcholine?
    Murray DJ; Gergis SD; Mehta MP; Sokoll MD
    Middle East J Anaesthesiol; 1986 Jun; 8(5):363-9. PubMed ID: 2875384
    [No Abstract]   [Full Text] [Related]  

  • 15. Suxamethonium--the relation between dose and response.
    Chestnut RJ; Healy TE; Harper NJ; Faragher EB
    Anaesthesia; 1989 Jan; 44(1):14-8. PubMed ID: 2539026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuromuscular blocking action of suxamethonium following intravenous and intramuscular administration.
    Schuh FT
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):399-403. PubMed ID: 7141759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged neuromuscular blockade following succinylcholine in a patient homozygous for the silent gene.
    Oshita S; Sari A; Fujii S; Yonei A
    Anesthesiology; 1983 Jul; 59(1):71-3. PubMed ID: 6859614
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose-response curves for suxamethonium in neonates, infants and children.
    Meakin G; McKiernan EP; Morris P; Baker RD
    Br J Anaesth; 1989 Jun; 62(6):655-8. PubMed ID: 2751920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of neuromuscular transmission--relationship between time factor and the development of phase II block induced by succinylcholine chloride].
    Murakami S; Kuze S; Kobayashi T; Hamabe N
    Masui; 1970 Sep; 19(9):937-46. PubMed ID: 5466639
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison in vitro of isoflurane and halothane potentiation of d-tubocurarine and succinylcholine neuromuscular blockades.
    Vitez TS; Miller RD; Eger EI; Van Nyhuis LS; Way WL
    Anesthesiology; 1974 Jul; 41(1):53-6. PubMed ID: 4834378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.